A Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study to Determine the Effect of Romiplostim on Health‐Related Quality of Life in Children with Primary Immune Thrombocytopenia and Associated Burden in Their Parents

BACKGROUND: Chronic immune thrombocytopenia (ITP) in children can negatively impact their health‐related quality of life (HRQoL) and impose a burden on their parents. This study sought to examine the effect of romiplostim on HRQoL and parental burden in children with primary ITP. PROCEDURE: This was...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Pediatr Blood Cancer
Auteurs principaux: Mathias, Susan D., Li, Xiaoyan, Eisen, Melissa, Carpenter, Nancy, Crosby, Ross D., Blanchette, Victor S.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2016
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5071741/
https://ncbi.nlm.nih.gov/pubmed/27037553
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.25984
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires